Table 1 Severity of CAPS-related symptoms at baseline
Symptom severity n(%) | Physician global assessment n= 35 | Patient global assessment n= 31 | Physician assessment | |||||
|---|---|---|---|---|---|---|---|---|
Skin rash n= 35 | Arthralgia n= 35 | Myalgia n= 35 | Headache/migraine n= 35 | Conjunctivitis n= 35 | Fatigue/migraine n= 35 | |||
Absent | 0 | 4 (12.9) | 4 (11.4) | 10 (28.6) | 15 (42.9) | 15 (42.9) | 5 (14.3) | 4 (11.4) |
Minimal | 2 (5.7) | 6 (19.4) | 6 (17.1) | 5 (14.3) | 4 (11.4) | 2 (5.7) | 8 (22.9) | 2 (5.7) |
Mild | 7 (20.0) | 8 (25.8) | 9 (25.7) | 10 (28.6) | 8 (22.9) | 9 (25.7) | 11 (31.4) | 7 (20.0) |
Moderate | 22 (62.9) | 9 (29.0) | 15 (42.9) | 7 (20.0) | 8 (22.9) | 3 (8.6) | 8 (22.9) | 14 (40.0) |
Severe | 4 (11.4) | 4 (12.9) | 1 (2.9) | 3 (8.6) | 0 | 6 (17.1) | 3 (8.6) | 8 (22.9) |